Recently, Artec announced the completion of Pre-A round of financing. This round of financing was led by Sequoia China… The funds will be used to continue to promote the research and development of a new generation of protein degraders based on ATTEC technology, including upgrading the drug target screening system, Expand the professional R&D team to promote the structural design, transformation and verification of small drug molecules.
media coverage
China Investment Network Venture Capital
This article is reprinted from: https://readhub.cn/topic/8hKhXwxFBJR
This site is for inclusion only, and the copyright belongs to the original author.